Biology Reference
In-Depth Information
References
1. Agca C, Seye C, Kashuba Benson CM, Rikka S, Chan AW, Weisman GA, Agca Y. (2009)
Development of a Novel Transgenic Rat Overexpressing the P2Y
2
Nucleotide Receptor Using
a Lentiviral Vector. J Vasc Res 46:447-58.
2. Ahmed SM, Rzigalinski BA, Willoughby KA, Sitterding HA, Ellis EF. (2000) Stretch-induced
injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and
neurons. J Neurochem 74:1951-60.
3. Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, Vinters HV, Head E, Perry G,
Lamanna JC, Friedland RP, Cotman CW. (2002) Atherosclerotic lesions and mitochondria
DNA deletions in brain microvessels as a central target for the development of human AD and
AD-like pathology in aged transgenic mice. Ann N Y Acad Sci 977:45-64.
4. Armulik A, Abramsson A, Betsholtz C. (2005) Endothelial/pericyte interactions. Circ Res
97:512-23.
5. Bagchi S, Liao Z, Gonzalez FA, Chorna NE, Seye CI, Weisman GA, Erb L. (2005) The P2Y
2
nucleotide receptor interacts with
α
v
integrins to activate G
o
and induce cell migration. J Biol
Chem 280:39050-7.
6. Baker OJ, Camden JM, Rome DE, Seye CI, Weisman GA. (2008) P2Y
2
nucleotide recep-
tor activation up-regulates vascular cell adhesion molecule-1 [corrected] expression and
enhances lymphocyte adherence to a human submandibular gland cell line. Mol Immunol 45:
65-75.
7. Barger AC, Beeuwkes R, 3rd, Lainey LL, Silverman KJ. (1984) Hypothesis: vasa vasorum
and neovascularization of human coronary arteries. A possible role in the pathophysiology of
atherosclerosis. N Engl J Med 310:175-7.
8. Beekhuizen H, van Furth R. (1993) Monocyte adherence to human vascular endothelium. J
Leukoc Biol 54:363-78.
9. Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF. (1994) Reduced malignancy
of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res 54:
832-7.
10. Bergfeld GR, Forrester T. (1992) Release of ATP from human erythrocytes in response to a
brief period of hypoxia and hypercapnia. Cardiovasc Res 26:40-7.
11. Boarder MR, Hourani SM. (1998) The regulation of vascular function by P2 receptors:
multiple sites and multiple receptors. Trends Pharmacol Sci 19:99-107.
12. Bodin P, Burnstock G. (2001) Purinergic signalling: ATP release. Neurochem Res 26:
959-69.
13. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak
HF, Senger DR. (1994) Osteopontin expression and distribution in human carcinomas. Am J
Pathol 145:610-23.
14. Chaulet H, Desgranges C, Renault MA, Dupuch F, Ezan G, Peiretti F, Loirand G, Pacaud P,
Gadeau AP. (2001) Extracellular nucleotides induce arterial smooth muscle cell migration via
osteopontin. Circ Res 89:772-8.
15. Ciccarelli R, Di Iorio P, Giuliani P, D
Alimonte I, Ballerini P, Caciagli F, Rathbone MP.
(1999) Rat cultured astrocytes release guanine-based purines in basal conditions and after
hypoxia/hypoglycemia. Glia 25:93-8.
16. Communi D, Janssens R, Suarez-Huerta N, Robaye B, Boeynaems JM. (2000) Advances
in signalling by extracellular nucleotides. the role and transduction mechanisms of P2Y
receptors. Cell Signal 12:351-60.
17. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA, Jr., Shin
WS, Liao JK. (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric
oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory
cytokines. J Clin Invest 96:60-8.
18. Di Virgilio F, Solini A. (2002) P2 receptors: new potential players in atherosclerosis. Br J
Pharmacol 135:831-42.
Search WWH ::
Custom Search